LSPedia, a leading provider of pharmaceutical compliance, serialization, and supply chain software solutions, announced a strategic partnership with Spring Bio Solution, a top global comparator sourcing and clinical supplies firm based in India. With more than 14 years of industry experience and a sterling reputation for compliance and regulatory excellence, Spring Bio Solution will play a key role in accelerating LSPedia’s global expansion and product adoption.
At the heart of this collaboration is LSPedia’s flagship platform, OneScan, the pharmaceutical industry’s leading global track-and-trace solution. OneScan empowers pharmaceutical companies to achieve comprehensive global compliance, including serialization, traceability, exception management, and automated data reporting—all within a single, integrated system.
Through this partnership, Spring Bio Solution will offer OneScan to pharmaceutical manufacturers across India, Europe, Singapore, and other key global markets, enabling them to stay ahead of evolving regulatory demands while increasing operational efficiency.
“Our collaboration with Spring Bio Solution strengthens our ability to deliver compliance innovation on a global scale,” said Daniel MacKinnon, SVP of Sales and Marketing at LSPedia. “With OneScan, Spring Bio Solution now brings the industry’s most advanced track-and-trace solution directly to global pharmaceutical manufacturers, delivering both regulatory confidence and complete supply chain visibility.”
Health Technology Insights: Zifo Launches AI App for Antibody Discovery on Snowflake
Spring Bio Solution has built a legacy of superior compliance standards, meticulous regulatory practices, and long-standing client trust in the comparator sourcing and clinical trial supplies space – making it the ideal partner for scaling OneScan’s global adoption. This partnership expands LSPedia’s international footprint while helping pharmaceutical companies navigate and simplify global compliance complexities.
While the US has mandated DSCSA for all products, serialization & traceability are becoming preferred and mandatory supply chain requirements within international markets including India.
Health Technology Insights: AvodahMed and Pulse4Pulse Team Up for AI Preventative Care
As part of this initiative, Spring Bio Solution will establish and lead LSPedia’s India entity operating from its Mumbai headquarters. Plans are already underway to extend this presence into Europe and Singapore, further supporting LSPedia’s strategic mission to serve pharmaceutical hubs worldwide.
“Spring Bio Solution has always prioritized client success, ensuring that pharmaceutical development and supply chains remain compliant and secure,” said Salim Shaikh Sadiq, Founder of Spring Bio Solution. “By joining forces with LSPedia and launching OneScan to our network, we’re giving clients access to world-class compliance technology that’s proven to transform track-and-trace operations on a global level.”
Key Benefits of the Partnership
- Seamless commercialization of OneScan and other LSPedia compliance solutions in India, Europe, Singapore, and additional global markets
- Comprehensive DSCSA compliance, serialization, and end-to-end traceability for manufacturers
- Stronger international footprint for LSPedia, driven by Spring Bio Solution’s regulatory expertise and global client relationships
- Empowerment of global manufacturers with the industry’s leading track-and-trace technology through OneScan
Health Technology Insights: Shilpa Medicare’s NorUDCA Makes History as First Approved NAFLD Therapy Worldwide
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
